期刊文献+

TNF-α和低氧对胰腺癌细胞表达VEGF-A、C的调节 被引量:2

Regulative Effect of TNF-α and Hypoxia on Expression of VEGF-A, C in Pancreatic Cancer
暂未订购
导出
摘要 目的:探讨细胞活素肿瘤坏死因子-α(TNF-α)、SNAP(S-Nitroso-Nacetyl-penicillamine)对胰腺癌细胞产生血管内皮生长因子A、C(VEGF-A、C)的调节。方法:用Northern杂交和Western杂交法分析6种人胰腺癌细胞株中VEGF-A、C基因和蛋白的表达;以TNF-α或SNAP刺激其中两个细胞株后用逆转录-聚合酶链式反应技术(RT-PCR)分析其VEGF-A、C基因的表达。结果:Northern杂交法显示这6种胰腺癌细胞株均有4.1kbVEGF-A基因和2.4kbVEGF-C基因的表达;Western杂交法显示它们均有分子量为43kD的VEGF-A蛋白质和分子量为55kD的VEGF-C蛋白质的表达。RT-PCR分析法显示:TNF-α使细胞株COLO-357产生VEGF-A、VEGF-CmRNA分别减少约1~2.5倍、1~2倍,使细胞株CAPAN-1产生VEGF-A、VEGF-CmRNA分别减少约1倍、1.6~2.5倍;而SNAP刺激细胞株COLO-357产生VEGF-AmRNA增加约5倍,刺激细胞株CAPAN-1产生VEGF-AmRNA增加约4倍,但对这两种细胞株产生VEGF-CmRNA均无明显刺激作用。结论:细胞活素TNF-α和低氧通过调节血管内皮生长因子A、C的表达而影响胰腺癌细胞的生物学特性,抑制癌细胞的增殖,促进其凋亡、死亡或进展、恶化。 Objective: To explore cytokines tumor necrosis factor-alpha (TNF-α) and S-Nitroso-Nacetyl-penicillamine (SNAP, nitrix oxide donor, leads to hypoxia state in the culture medium.) regulate to expression of vascular endothelial growth factor-A, C (VEGF-A, C) in pancreatic cancer cells. Methods: The method of Northern blot and Western blot was respectively used to analyze the expression of gene and protein of VEGF-A, C in six human pancreatic cancer cells lines and the reversetranscription polymerase chain reaction (RT-PCR) method was used to analyze VEGF-A, C gene expression in two tested cell lines under the stimulation with TNF-α or SNAP. Results: Northern blot analysis revealed the presence of the 4.1-kb VEGF-A mRNA transcript and 2.4-kb VEGF-C mRNA transcript in all six tested cell lines; Western blot analysis revealed the presence of Mr 43-kDa VEGFA protein and Mr 55-kDa VEGF-C protein in all the cell lines. RT-PCR analysis showed that by stimulation with TNF-α, there were a 1- to 2.5-fold and 1- to 2-fold decrease in COLO-357 cell line, and a 1-fold and 1.6- to 2.5- fold decrease in CAPAN-1 cell line in the level of VEGF-A and of VEGF-C mRNA, respectively; The level of VEGF-A mRNA increased five times in COLO-357 cell line and four times in CAPAN-1 cell line by stimulation with SNAP, however, no effect was found in the two cell lines by stimulation with SNAP. Conclusions: Cytokines TNF-α and SNAP affect the biological character of pancreatic cancer cells by regulating the expression of VEGF-A, VEGF-C, and promote the apotosis and death or the growth and distant metastasis of pancreatic cancer cells.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2005年第15期852-855,共4页 Chinese Journal of Clinical Oncology
基金 教育部留学回国人员科研启动基金项目资助(编号:教外司留[2002]247号)
关键词 胰腺肿瘤 血管内皮生长因子A、C 肿瘤坏死因子 低氧 Pancreatic neoplasms Vascular endothelial growth factor-A, -C Tumor necrosis factor Hypoxia
  • 相关文献

参考文献18

  • 1Yamamoto M, Ohashi O, Saitoh Y. Studies on TNM classification of carcinoma of the exocrine pancreas [J]. Gan to Kagaku Ryoho[Jpn J Cancer Chemother in Japanese], 1998, 25 ( 1 ): 143 ~ 149.
  • 2Folkmann J. Angiogenesis in cancer, vascular, rheumatoid and other disease[J]. Nature (Med), 1995, 1(1): 27~31.
  • 3Yonemura Y, Endo Y, Fujita H, et al. Role of vascular endothelial growth factor-C expression in the development of lymph node metastasis in gastric cancer[J]. Clin Cancer Res, 1999, 5(7):1823~1829.
  • 4Tang RF, ItakuraJ, Aikawa T, et al. Overexpression of lymphangiogenic growth factor VEGF-C in human pancreatic cancer[J].Pancreas, 2001, 22(3): 285~292.
  • 5唐瑞峰,张风瑞,彭利,王顺祥,王曙霞,肖燕.血管、淋巴管内皮生长因子在胰腺癌中的表达[J].临床肝胆病杂志,2004,20(4):230-232. 被引量:4
  • 6Chin K, Kurashima Y, Ogura T, et al. Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells[J]. Oncogene, 1997, 15(4): 437~442.
  • 7Kimura H, Ogura T, Kurashima Y, et al. Effects of nitric oxide donors on vascular endothelial growth factor gene induction [J].Biochem Biophys Res Commun, 2002, 296(4): 976~982.
  • 8Itakura J, Ishiwata T, Shen B, et al. Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer[J]. IntJ Cancer, 2000, 85(1): 27~34.
  • 9Kellokumpu-Lehtinen P, Talpaz M, Harris D, et al. Leukemiainhibitory factor stimulates breast, kidney and prostate cancer cell proliferation by paracrine and autocrine pathways[J]. Int J Cancer,1996, 66(4): 515~519.
  • 10Riegel AT, Wellstein A. The potential role of the heparin-binding growth factor pleiotrophin in breast cancer [J]. Breast Cancer Res Treat, 1994, 31(2-3): 309~314.

二级参考文献11

  • 1Eriksson U, Alitalo K. Structure, expression and receptor - binding properties of novel vascular endothelial growth factors[ M ]. In: Claesson - Welsh L. Vascular growth factors and angiogenesis. Berlin: Springer Verlag Press, 1999:41. Curr Top Microbiol
  • 2Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothelial growth factor, VEGF - C, is a ligand for the Fit - 4( VEGFR - 3) and KDR (VEGFR- 2) receptor tyrosine kinases[J]. EMBO J, 1996,15(2) :290- 98.
  • 3Ogawa S, Oku A, Sawano A, et al. A novel type of vascular endothelial growth factor, VEGF - E (NZ - 7 VEGF), preferentially utilizes KDR/Flk- 1 receptor and carries a potent mitotic activity without heparinbinding domain[J]. J Bio Chem, 1998, 273(47):3127
  • 4Sobin LH, Fleming LD. TNM Classification of Malignant Tumors[J]. Union Internationale Contre le cancer and the American Joint Committee on Cancer. Cancer, 1997,80(9):1803-4.
  • 5Ferrara N. Vascular endothelial growth factor: molecular and biological sspects[M].In: Claesson- Welsh L. Vascular growth factors and angiogenesis. Berlin: Springer- Vertag Press, 1999:1 - 30.
  • 6Yonemura Y, Endo Y, Fujita H, et al. Role of vascular endothelial growth factor C expression in the develqpment of lymph node metastasis in gastric cancer[J]. Clin Cancer Res, 1999, 5(7):1823 -9.
  • 7Tang RF, Itkura J,Aikawa T, et al. Overexression of lymphangiogenic growth factor VEG F- C in human pancreatic cancer[ J]. Pancreas,2001,22(3) :285 - 92.
  • 8Pancreas (ICD- O C25.0- 2,8)UICC TNM Classification of malignant tumors[M].5th ed. In: Sobin LH, Wittekind C New York, John Wiley and Sons, 1997:87-90.
  • 9Takahashi Y, Cleary KR, MaiM, et al. Significance of vessel count and vasular endothelial growth factor and its receptor (KDR) in intestinaltype gastric cancer[J]. Clin Cancer Res, 1996, 2(10):1679-84.
  • 10Itakura J, Ishiwata T, Shen B, et al. Concomitant over- expression of vascular endothelial growth factor and its receptors in pancreatic cancer [J]. IntJ Cancer, 2000,85(1):27-34.

共引文献3

同被引文献25

  • 1何素芳,王志刚,任爱农,高燃.红花多糖对H22荷瘤小鼠的抑瘤作用及瘤细胞VEGF,Ki67表达的影响[J].中国中药杂志,2009,34(6):795-797. 被引量:25
  • 2梁颖,张晓莉,陶冀,王亚贤.红花多糖对人肝癌SMMC-7721细胞增殖的抑制作用[J].中医药学报,2011,39(5):32-35. 被引量:25
  • 3张圣林,邱法波,吴力群.Th1/Th2偏移与恶性肿瘤关系的研究进展[J].细胞与分子免疫学杂志,2005,21(B03):113-114. 被引量:21
  • 4唐瑞峰,王曙霞,彭利,王顺祥,张萌,肖燕,张风瑞.细胞因子和低氧对胰腺癌细胞表达血管内皮生长因子A、C的调节[J].肿瘤,2007,27(1):30-33. 被引量:2
  • 5Kedra B, Popiela T, Sierzega M, et al. Prognostic factors of long- term survival after resective procedures for pancreatic cancer[J]. Hepatoga-stroenterology, 2001,48 ( 42 ) : 1762-1766.
  • 6Benassai G, Mastrorilli M, Quarto G, et al. Factors influencing survival after resection for ductal adeno-carcinoma of the head of the pancreas[J]. J Surg Oncol,2000,73(4) :212-218.
  • 7Kuhlmann KF, DE Castro SM, Wesseling JG, et al. Surgical treatment of pancreatic adenocarcinoma: actual survival and prognostic factors in 343 patients[J]. Eur J Cancer, 2004, 40 (4) : 549-558.
  • 8Veikkola T,Jussila I., Makinen T, et al. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphan- giogenesis in transgenic mice[J]. EMBO J,2001,20(6):1223-1231.
  • 9Nathanson SD,Zarbo R J, Wachna DL, et al. Microvessels that prodict axillary lymph node metastases in patients with breast cancer[J]. Arch Surg, 2000, 135 (5) : 586-593.
  • 10Salven P, Hattori K, Heissing B, et al. Interleukin-1alpha promotes angiogenesis in vivo VEGF-VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion[J]. FASEB J,2002,16(11 ) : 1471-1473.

引证文献2

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部